Parathyroid Archives - Endocrinology Advisor

Primary Hyperparathyroidism: Diagnosis and Management

By

Amit Akirov, MD

November 5, 2019

This report provides an update on the use of diagnostic tests for asymptomatic primary hyperparathyroidism in clinical practice.

General Endocrinology

Timing of Serum Parathyroid Hormone Levels May Predict Postoperative Hypocalcemia

By

Anna Kitabjian

June 13, 2018

Serum intact parathyroid hormone levels may be an early marker to predict postthyroidectomy hypocalcemia.

General Endocrinology

Hypoparathyroidism Treatment Granted Orphan Drug Designation

By

Steve Duffy

June 7, 2018

TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore PTH to physiologic levels, normalizing blood and urinary calcium levels, serum phosphate levels and bone turnover.

Thyroid

Effects of ARB, Vitamin D3 on Parathyroid Hormone and Aldosterone

By

Roxanne Nelson, BSN, RN

May 30, 2018

Investigators examined whether short-term treatment with an angiotensin II receptor blocker and/or vitamin D3 reduced PTH levels.

Bone Metabolism

Preterm Infant Vitamin D Level Affects Calcium and Bone Health

By

Rita Aghjayan

May 23, 2018

Vitamin D levels in preterm infants are significantly correlated with optimal calcium homeostasis and bone mineralization of the femur.

Thyroid

Diagnostic Value of Shear Wave Elastography for Parathyroid Adenomas

By

Anna Kitabjian

April 3, 2018

Shear wave elastography can be a useful tool in the preliminary diagnostics of parathyroid adenomas.

Pediatric Endocrinology

Predicting Hypocalcemia in Children Following Thyroidectomy: Is PTH Level Useful?

By

Lauren Biscaldi

October 31, 2017

While parathyroid hormone levels may be used to anticipate calcium decline, a “normal” PTH level does not always correctly predict postoperative calcium level.

Thyroid

Parathyroidectomy for Secondary, Tertiary Hyperparathyroidism Increases Morbidity and Mortality

By

Jeff Craven

July 11, 2017

After parathyroidectomy, morbidity and mortality rates were considerably higher in patients with secondary and tertiary vs primary hyperparathyroidism.